Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-12-09

Clinical Trial Update: SUBLOCADE Rapid Initiation Study [Phase 4]

View source ↗

Summary

Phase 4 study evaluating rapid initiation of SUBLOCADE for opioid use disorder, with results posted in December 2020.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • SUBLOCADE (buprenorphine extended-release)

Snippet

Sponsor: Indivior Inc. | Conditions: Opioid-use Disorder | Phase 4 | Status: COMPLETED | Results posted: 2020-12-09